Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Research Jiangsu Hengrui Pharmaceuticals Co.,Ltd (0BO) on Bullrun: valuation model: 24.1% overvalued, market cap EUR 38.83B, P/E 36.6, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker0BO
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Valuation signal24.1% overvalued
• Market capEUR 38.83B
• P/E36.6
• Dividend yield0.4%
• Financial periodQ1 2026
• RevenueEUR 8.14B
• Net incomeEUR 2.28B
• Free cash flowEUR 81.63M
• Gross margin86.6%

Valuation Snapshot

Bullrun's latest valuation model marks Jiangsu Hengrui Pharmaceuticals Co.,Ltd as 24.1% overvalued; latest market cap is EUR 38.83B; P/E is 36.6; dividend yield is 0.4%.

About Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Frequently asked questions

Is Jiangsu Hengrui Pharmaceuticals Co.,Ltd overvalued or undervalued?

Bullrun's valuation model currently marks Jiangsu Hengrui Pharmaceuticals Co.,Ltd as 24.1% overvalued.

What is Jiangsu Hengrui Pharmaceuticals Co.,Ltd's market cap?

Jiangsu Hengrui Pharmaceuticals Co.,Ltd's market capitalization is EUR 38.83B.

What is Jiangsu Hengrui Pharmaceuticals Co.,Ltd's P/E ratio?

Jiangsu Hengrui Pharmaceuticals Co.,Ltd's price-to-earnings (P/E) ratio is 36.6.

Does Jiangsu Hengrui Pharmaceuticals Co.,Ltd pay a dividend?

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has a dividend yield of 0.4%.

What does Jiangsu Hengrui Pharmaceuticals Co.,Ltd do?

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.